<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2025.1629018</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Worldwide distribution of human pythosis and biological characteristics of a <italic>Pythium insidiosum</italic> strain susceptible to antibiotics from China: a dual-scale study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Liu</surname> <given-names>Xiaoyun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Diao</surname> <given-names>Qiuyue</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Mingliang</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/3243931/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname> <given-names>Yuting</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1600392/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Liang</surname> <given-names>Jiayin</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2934946/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Cui</surname> <given-names>Zehua</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1101853/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Haiyan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1905628/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>He</surname> <given-names>Huiling</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Huang</surname> <given-names>Jiabao</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Ren</surname> <given-names>Hao</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2795728/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhou</surname> <given-names>Fengli</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Shan</surname> <given-names>Tijiang</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1458790/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Liao</surname> <given-names>Xiaopin</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/202327/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Sun</surname> <given-names>Jian</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/176826/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhang</surname> <given-names>Kouxing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1577267/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of General Medicine of The Third Affiliated Hospital of Sun Yat-sen University</institution>, <city>Guangzhou</city>, <country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou</institution>, <city>Guangdong</city>, <country country="cn">China</country></aff>
<aff id="aff3"><label>3</label><institution>Department of General ICU of The Third Affiliated Hospital of Sun Yat-sen University</institution>, <city>Guangzhou</city>, <country country="cn">China</country></aff>
<aff id="aff4"><label>4</label><institution>Department of Clinical Laboratory of The Third Affiliated Hospital of Sun Yat-sen University</institution>, <city>Guangzhou</city>, <country country="cn">China</country></aff>
<aff id="aff5"><label>5</label><institution>College of Forestry and Landscape Architecture, South China Agricultural University</institution>, <city>Guangzhou</city>, <country country="cn">China</country></aff>
<author-notes>
<corresp id="c001"><label>&#x002A;</label>Correspondence: Jian Sun, <email xlink:href="mailto:jiansun@scau.edu.cn">jiansun@scau.edu.cn</email></corresp>
<corresp id="c002">Kouxing Zhang, <email xlink:href="mailto:zhkoux@mail.sysu.edu.cn">zhkoux@mail.sysu.edu.cn</email></corresp>
<fn fn-type="equal" id="fn002"><label>&#x2020;</label><p>These authors have contributed equally to this work and share first authorship</p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-12-09">
<day>09</day>
<month>12</month>
<year>2025</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>12</volume>
<elocation-id>1629018</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>19</day>
<month>10</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>11</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Liu, Diao, Li, Yang, Liang, Cui, Zhang, He, Huang, Ren, Zhou, Shan, Liao, Sun and Zhang.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Liu, Diao, Li, Yang, Liang, Cui, Zhang, He, Huang, Ren, Zhou, Shan, Liao, Sun and Zhang</copyright-holder>
<license>
<ali:license_ref start_date="2025-12-09">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Pythiosis, caused by <italic>Pythium insidiosum</italic> (<italic>P. insidiosum</italic>), is an emerging disease with high mortality and morbidity. Despite its clinical severity and geographical strain variations, diagnostic and treatment challenges persist.</p>
</sec>
<sec>
<title>Materials and methods</title>
<p>We queried PubMed and Google Scholar for &#x201C;<italic>P. insidiosum</italic>&#x201D; and &#x201C;pythiosis,&#x201D; 1084 human pythiosis cases to generate a corresponding distribution map. Molecular biology, morphology, modified sporulation technique, and microscopic observation were employed to understand the biological properties of <italic>P. insidiosum</italic> with a strain of <italic>P. insidiosum</italic> isolated from a patient in Guangzhou. Drug susceptibility studies on the isolate were conducted both <italic>in vitro</italic> and <italic>in vivo</italic>.</p>
</sec>
<sec>
<title>Results</title>
<p>Molecular biology, morphology, and biological processes confirmed that this strain was <italic>P. insidiosum</italic>. Epidemiological investigations have revealed that India and Thailand are hotspots for human pythiosis, and sporadic cases are increasing in China, the Americas, and Europe. The modified method of zoospore induction achieved 250-fold greater than the traditional method within 24 h. <italic>In vitro</italic> drug testing demonstrated superior antibiotic sensitivity (doxycycline (DOX) MIC 4 &#x03BC;g/mL; azithromycin (AZM) MIC 8 &#x03BC;g/mL) versus antifungals (&#x003E; 128 &#x03BC;g/mL). Subcutaneous infection models in immunocompromised mice showed 80 and 90% survival with oral AZM/DOX monotherapy versus 20% in controls (<italic>P</italic> &#x003C; 0.05), correlating with reduced hepatic fungal burdens and attenuated neutrophilic periarteritis.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The distribution map underscores pythiosis as a growing climate-sensitive disease that requires enhanced surveillance in non-endemic regions. The modified method of zoospore induction and microstructure observation with Transmission Electron Microscopy (TEM) may be helpful for the rapid and sensitive detection of <italic>P. insidiosum</italic>. We also provided theoretical and technical support for the effective treatment of pythiosis in humans and animals with DOX and AZM in China, which offers novel insights into the potential of certain antibiotics as effective treatments.</p>
</sec>
</abstract>
<kwd-group>
<kwd>oomycetes</kwd>
<kwd>pythiosis</kwd>
<kwd><italic>Pythium insidiosum</italic></kwd>
<kwd>epidemiology</kwd>
<kwd>identification</kwd>
<kwd>antimicrobial treatment</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by Guangdong Major Project of Basic and Applied Basic Research (Grant No. 2020B0301030007).</funding-statement>
</funding-group>
<counts>
<fig-count count="7"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="44"/>
<page-count count="13"/>
<word-count count="7732"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Infectious Diseases: Pathogenesis and Therapy</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p><italic>Pythium insidiosum</italic> (<italic>P. insidiosum</italic>), an oomycete pathogen of the <italic>Stramenopila</italic> lineage, was previously misclassified under the &#x201C;fungus-like&#x201D; category (<xref ref-type="bibr" rid="B1">1</xref>). <italic>P. insidiosum</italic> is not the only pseudofungal pathogen responsible for neglected infectious diseases. Organisms such as <italic>Prototheca</italic> spp. and <italic>Rhinosporidium seeberi</italic> also face diagnostic and therapeutic challenges due to their atypical biological nature and limited awareness among clinicians (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Additionally, other oomycetes, such as <italic>Lagenidium</italic> spp., have been increasingly recognized as emerging pathogens in animals and humans (<xref ref-type="bibr" rid="B4">4</xref>). Therefore, fungus-like pathogens require more attention from both clinicians and researchers.</p>
<p>As the sole Pythium species causing mammalian pythiosis, it is widespread in temperate, tropical, and subtropical areas and is a major ecological species in swamps (<xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B7">7</xref>). During the biphasic invasion cycle of <italic>P. insidiosum</italic>, motile zoospores, the primary infectious propagules, differentiate from sporangia and germinate into host-penetrating hyphae that establish tissue infection (<xref ref-type="bibr" rid="B8">8</xref>). <italic>P. insidiosum</italic> differs from true fungi in cell wall composition (lack of chitin but is rich in cellulose and &#x03B2;-glucans), mitochondrial structure, actin cytoskeleton, protein repertoire, incomplete sterol biosynthesis pathway, 70s ribosome and biflagellate zoospores that can actively swim in water for 20&#x2013;30 min (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B9">9</xref>). Human pythiosis presents in three major clinical forms: vascular, cutaneous/subcutaneous, and ocular (<xref ref-type="bibr" rid="B10">10</xref>). Animal pythiosis typically manifests as cutaneous proliferative, ulcerative nodules, or tumor-like masses on the limbs, scrotum, or abdomen, and gastrointestinal forms produce weight loss, vomiting, and segmental granulomatous enteritis (<xref ref-type="bibr" rid="B11">11</xref>). The diagnosis of pythiosis remains challenging and requires diligent records of medical history, physical examination of the patient, and laboratory information, including direct microscopic observation, culture identification and zoospore induction, serum <italic>P. insidiosum</italic>-specific antibodies, histological examination, and molecular analysis (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B12">12</xref>). Differential diagnosis of pythiosis from other fungal infections, such as mucormycosis and entomophthoramycosis, is crucial. Mucormycosis is characterized by rapid tissue necrosis and angioinvasion, leading to thrombosis and infarction of the affected tissue. Entomophthoramycosis often presents with chronic indolent lesions and a granulomatous inflammatory response (<xref ref-type="bibr" rid="B13">13</xref>). Laboratory methods are helpful for accurate diagnosis. Motile zoospores in water can distinguish pythiosis from other fungi (<xref ref-type="bibr" rid="B14">14</xref>). Molecular methods, such as PCR assays, can also be used to differentiate <italic>P. insidiosum</italic> from other pathogens (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>).</p>
<p>Pythiosis burden analyses reveal a strikingly conflicting reality: 79.2% of affected animals were in America and Brazil, whereas 94.3% of human cases were in India and Thailand (<xref ref-type="bibr" rid="B17">17</xref>). The geographic distribution of this disease is increasing and poses a significant public healthh threat with high morbidity (vascular: 78%, ocular: 79%) and mortality (disseminated: 100%, vascular: 40%) (<xref ref-type="bibr" rid="B6">6</xref>). Pythiosis is commonly treated with surgical resection, immunotherapy, and antibacterial drugs (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Most treatments for pythiosis are surgical, although this course of action can considerably increase the economic burden, postoperative complications, and uncontrolled infections. The therapeutic properties of <italic>P. insidiosum</italic> antigens need to be improved for better prognosis in patients with pythiosis (<xref ref-type="bibr" rid="B19">19</xref>). Antimicrobial medication therapy achieves therapeutic efficacy by eliminating invasive microorganisms while minimizing costs and adverse effects. The repurposing of existing drugs is a safe and efficient strategy for the anti-<italic>P. insidiosum</italic> (<xref ref-type="bibr" rid="B20">20</xref>). However, the results of antimicrobials against <italic>P. insidiosum</italic> are inconsistent <italic>in vitro</italic> and <italic>in vivo</italic>, and no standardized antimicrobial susceptibility testing (AST) framework exists for this World Health Organization-listed priority oomycete. Therefore, understanding the geographic distribution of <italic>P. insidiosum</italic> is critical for developing targeted prevention strategies and optimizing the clinical management of pythiosis, particularly in regions experiencing a progressive rise in case incidence, such as China.</p>
<p>To comprehend the biological properties of <italic>P. insidiosum</italic> and make the effort to overcome this difficult clinical challenge, we observed the transition of <italic>P. insidiosum</italic> (<italic>GZ2020</italic>) (<xref ref-type="bibr" rid="B16">16</xref>) from hyphae to spore form using a microscope, and we used a modified sporulation technique to produce zoospores more quickly and plentifully. Importantly, we conducted drug sensitivity tests <italic>in vitro</italic> and <italic>in vivo</italic> on infected mouse models, which are sensitive to some antibacterial drugs. Our results will help repurpose existing drugs as a safe and efficient strategy against <italic>P. insidiosum</italic>.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="S2.SS1">
<label>2.1</label>
<title>Study design</title>
<p>We isolated a strain of <italic>P. insidiosum</italic> (<italic>GZ2020</italic>) from a patient with skin ulcers. This pathogen was identified as <italic>P. insidiosum</italic> based on mycelial morphology on different media and molecular biology. We constructed a phylogenetic tree based on the genes to determine their evolutionary relationship. We observed its biological processes using scanning electron microscopy (SEM) and its inner structure using transmission electron microscopy (TEM). Additionally, we mapped the distribution of human pythiosis using the data from PubMed and Google Scholar and visualized it with R (4.4.1). We improved the sporulation induction method for <italic>P. insidiosum</italic>. We performed drug susceptibility tests with antibacterial and antifungal agents <italic>in vitro</italic> and drug susceptibility tests <italic>in vivo</italic> using a mouse model. The study design is shown in <xref ref-type="supplementary-material" rid="FS1">Supplementary Figure 1</xref>.</p>
</sec>
<sec id="S2.SS2">
<label>2.2</label>
<title>Epidemiological distribution</title>
<p>We searched the keywords &#x201C;<italic>P. insidiosum</italic>&#x201D; and &#x201C;pythiosis&#x201D; in PubMed<sup><xref ref-type="fn" rid="footnote1">1</xref></sup> (accessed date: 8 March 2025) and Google Scholar<sup><xref ref-type="fn" rid="footnote2">2</xref></sup> (accessed date: 11 March 2025). The clinical data of human pythiosis cases, including publication year, number of cases, and country of origin, were extracted and collected from the obtained literature. All collected cases met at least one of the following diagnostic criteria: (i) microbiological methods (such as culture identification, zoospore induction, and microscopic examination), (ii) histological assessment (histological examination and staining), and (iii) serological tests. (iv) Molecular assays. A total of 120 articles and 1314 cases were included. Potentially duplicated pythiosis patients were excluded from the study to prevent overestimation of the overall case number. The main criteria for considering a case as a duplicate were an identical institution, overlapping study period, and identical disease manifestation. 86 studies, including 1084 cases (<xref ref-type="supplementary-material" rid="DS1">Supplementary Data Sheet 1</xref>), were enrolled in the epidemiological distribution map. One case potentially infected in Brazil or Colombia was attributed to Colombia in this analysis.</p>
</sec>
<sec id="S2.SS3">
<label>2.3</label>
<title>Isolation and identification</title>
<p>The <italic>P. insidiosum</italic> (<italic>GZ2020</italic>) was isolated from a skin infection patient from the Third Affiliated Hospital of Sun Yat-sen University. We placed infected tissues on blood agar plates or 2% Sabouraud Dextrose Agar (Guangdong Huankai Microbial Technology Co., Ltd. Guangzhou, China) and incubated at 37 &#x00B0;C for 2 days. After hyphae growth, the culture was purified by passaging using dot-planting. According to previous studies, hyphae were picked and stained with lactophenol cotton blue (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>).</p>
<p>Genomic DNA from mycelia was extracted with a DNA Extraction Kit (Shanghai Shenggong Biological Engineering Co., Ltd. Shanghai, China), and gDNA amplification was performed using primers for different genes (<xref ref-type="bibr" rid="B15">15</xref>). We amplified gene LSU and COI as described by Robideau et al. (<xref ref-type="bibr" rid="B12">12</xref>) and Bala et al. (<xref ref-type="bibr" rid="B23">23</xref>) with only minor modifications: the reaction volume increased to 50 &#x03BC;L, the denaturation shortened to 2 min and the extension time lengthened to 80s for LSU and the extension time lengthened to 70s for COI. The polymerase chain reaction (PCR) products were separated by 1% agarose gel electrophoresis and stained for observation.</p>
<p>We spliced the sequences into complete sequences using DNAMAN (version 9.0, United States) and compared the amplified primer sequences with BLAST software on the NCBI website. Homology searches were performed in the GenBank database and compared with the identified <italic>P. insidiosum</italic> sequences.<sup><xref ref-type="fn" rid="footnote3">3</xref></sup> We utilized MAFTT (Version 7.0, JPN) to download sequences with high similarity and similar genera. We then used MEGA (Version 12.0, United States) with the maximum likelihood method to construct a phylogenetic tree to determine whether they were in the same branch as <italic>P. insidiosum</italic>.</p>
</sec>
<sec id="S2.SS4">
<label>2.4</label>
<title>Zoospore induction</title>
<p>This study used a modified method to induce sporulation (<xref ref-type="fig" rid="F1">Figure 1A</xref>) in <italic>P. insidiosum</italic>, which requires an induction solution combined with plant sap. Liquid A included K<sub>2</sub>HPO<sub>4</sub> &#x22C5; 3H<sub>2</sub>O (Tianjin Yongda Chemical Reagent Co., Ltd. Tianjin, China)11.4 g, KH<sub>2</sub>PO<sub>4</sub> (Tianjin Yongda Chemical Reagent Co., Tianjin, China) 6.8 g, (NH<sub>4</sub>)<sub>2</sub>HPO<sub>4</sub> (Tianjin Yongda Chemical Reagent Co Tianjin, China) 6.6 g, distilled water 50 mL, Liquid B includes MgCI<sub>2</sub> &#x22C5; 6H<sub>2</sub>O (Tianjin Yongda Chemical Reagent Co., Ltd. Tianjin, China) 2.54 g, CaCl<sub>2</sub> &#x22C5; 2H<sub>2</sub>O (Tianjin Yongda Chemical Reagent Co., Ltd. Tianjin, China)1.84 g, and distilled water 25 mL. Induction solution: Mix 0.5 mL of Liquid A and 0. 1 mL of Liquid B in 1,000 mL of distilled water, adjusted pH range 7.0 &#x223C; 7.1, stored at 4 &#x00B0;<italic>C</italic> (<xref ref-type="bibr" rid="B24">24</xref>). Extraction of plant sap: Annona squamosa L leaves (100 g) were weighed, distilled water (500 mL) was added, and sap was extracted, sterilized, and stored at 4 &#x00B0;C. Agar plugs with hyphae on the edge of fresh blood agar plates were inserted into 2% Sabouraud Dextrose Agar plates and incubated at 37 &#x00B0;C for 1 week. The agar plugs with mycelium were placed in centrifuge tubes with 2% Sabouraud Dextrose Broth (Guangdong Huankai Microbial Technology Co., Ltd. Guangzhou, China) culture solution and incubated at 37 &#x00B0;C and 180 rpm for 4 h. The broth was removed from the centrifuge tubes, and an equal amount of distilled water was added and incubated at 37 &#x00B0;C and 180 rpm for 1 h. The centrifuge tubes were incubated with an induction solution and plant sap at a volume ratio of 1:1 at 37 &#x00B0;C and 180 rpm for 10&#x2013;24 h. We observed the production of zoospores and the release of zoospores from sporangia under a light microscope (MI52-N, Guangzhou Mingmei Optoelectronics Technology Co., Ltd., Guangzhou, China). We also compared the zoospore yield between our modified method and the traditional method (<xref ref-type="bibr" rid="B24">24</xref>). We used a Neubauer chamber to count the zoospores after zoosporogenesis (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). We counted the zoospores on the leaves using a light microscope according to the traditional method.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Induction of zoospore analysis. The step-by-step process of inducing spore formation <bold>(A)</bold>, Microscopic images of the sporulation of modified method <bold>(B)</bold>. Microscopic images of the sporulation using the traditional method <bold>(C)</bold>. A comparative graph of spore yield between the traditional method and the modified method <bold>(D)</bold>. All data are presented as mean &#x00B1; SD, and the significances were determined by one-way ANOVA (&#x002A;&#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.0001).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1629018-g001.tif">
<alt-text content-type="machine-generated">A four-part image: A shows a flowchart detailing the process of extracting and examining zoospores from foliage using a blender, culture, and microscope. B shows a microscopic image of zoospores with a scale of 200 micrometers. C provides a closer view of the zoospores at 100 micrometers scale. D features a bar graph comparing zoospore counts between traditional and modified methods, indicating significantly higher counts in the modified method.</alt-text>
</graphic>
</fig>
</sec>
<sec id="S2.SS5">
<label>2.5</label>
<title>Observation with SEM and TEM</title>
<p>Oomycete preparations were used to remove <italic>P. insidiosum</italic> from the induction solution. We soaked the samples in 1 mL of 2.5% glutaraldehyde fixative and rinsed them with 0. 1 mL phosphate buffer, washed them in 0. 1 mL phosphate buffer three times and fixed them in 1% osmium solution. After drying the samples with ethanol and dehydrating them (30,50,70,80, and 90% once for 10 min per concentration, and 100% 2 times for 10 min), the <italic>developmental cycle of P. insidiosum</italic> was observed using SEM (Verios 460, Field Electron and Ion Company (FEI), Brno, Czech Republic).</p>
<p>To evaluate the ultrastructural features of the hyphae, we applied an oomycete preparation to remove the hyphae from the induction solution. Samples were placed in 1 mL of a fixative solution containing 2.5% glutaraldehyde and 2% paraformaldehyde (2.5% GA + 2% PFA). The samples were then rinsed with 0.1 mL of phosphate buffer three times and fixed with a solution of osmium (1% osmium + 1% potassium ferricyanide, prepared at 0.2 M Morphotropic Phase Boundary). Subsequently, the samples were stained with uranyl acetate, dehydrated with ethanol (30,50,70,80, and 90% once for 15 min per concentration, and 100% 2 times for 20 min), washed with 100% acetone 2 times for 10 min, and infiltrated with a mixture of acetone and embedding agent (resin) (volume ration were 3:1,1:1 and1:3). Finally, the samples were polymerized for 24 h at 70 &#x00B0;C (<xref ref-type="bibr" rid="B27">27</xref>). 70&#x2013;100 nm thick were obtained using an ultrathin sectioning machine. The sections were then placed on a nickel grid and stained with uranyl acetate and lead citrate. The internal morphology of the hyphae was examined using TEM (Talos F200S, FEI, Brno, Czech Republic) on a nickel grid.</p>
</sec>
<sec id="S2.SS6">
<label>2.6</label>
<title>Drug sensitivity <italic>in vitro</italic></title>
<p>The susceptibility of <italic>P. insidiosum</italic> was tested using the broth microdilution method, following the modified Clinical and Laboratory Standards Institute (CLSI) M38-A2 protocol (<xref ref-type="bibr" rid="B28">28</xref>). In our study, zoospores were used for the drug susceptibility assays. The zoospores were resuspended in RPMI-1640 (Thermo Fisher Scientific, Waltham, United States) broth with a pH of 6.9&#x2013;7.1, supplemented with 0.164 mL of 3-[N-morpholino] propane sulfonic acid (Guangzhou Xinglang Biotechnology Co., Ltd., Guangzhou, China), to achieve a final concentration of 2&#x2013;3 &#x00D7; 10<sup>&#x2227;</sup>3 cells/mL (<xref ref-type="bibr" rid="B29">29</xref>). Microdilution 96-well plates were utilized to test the zoospore suspension (inoculum) against either RPMI-1640 alone (as a no-drug control) or various drug concentrations. After 24 h of incubation at 37 &#x00B0;C, the minimum inhibitory concentration (MIC) was determined according to other studies (<xref ref-type="bibr" rid="B30">30</xref>). We conducted three biological replicates to assess the sensitivity of <italic>P. insidiosum</italic> to several antibiotics (doxycycline (DOX), tetracycline (TET), erythromycin (ERY), and azithromycin (AZM]) (Shanghai Yuanye Biotech Co., Ltd., Shanghai, China), tigecycline (TIG) (Guangzhou Zhuorui Biotech Co., Ltd., Guangzhou, China), chloramphenicol (CHL), and linezolid (LZD) (Shanghai Maclin Biochemical Technology Co., Ltd., Shanghai, China), gentamicin (GCN) (Beijing Pubuxin Biotech Co. Ltd., Beijing, China), and florfenicol (FFC)(Guangzhou Weigu Technology Co., Ltd., Guangzhou, China), compound sulfamethoxazole (SMZ/TMP) (Shandong Fangming Pharmaceutical Group Co. Ltd., Shangdong, China) and antifungals (fluorocytosine and itraconazole [(Shanghai Yuanye Biotech Co., Ltd., Shanghai, China), amphotericin B (Shanghai Aladdin Biochemical Technology Co., Ltd., Shanghai, China), and fluconazole (Guangzhou Zhuorui Biotech Co., Guangzhou, China)].</p>
</sec>
<sec id="S2.SS7">
<label>2.7</label>
<title>Animal model and drug sensitivity <italic>in vivo</italic></title>
<p>This study utilized 7-week-old female BALB/c mice (18&#x2013;22 g) that were pathogen-free and obtained from the Guangdong Medical Lab Animal Center in Guangzhou, China. The animal experimental procedures were conducted following the guidelines of the South China Agricultural University (SCAU) Institutional Laboratory Animal Care and Use and were approved by the SCAU Institutional Ethics Committee (2020C407). To induce neutropenia, two intraperitoneal injections of cyclophosphamide were administered at doses of 150 mg/kg on 4 days before infection and 100 mg/kg on 1 day before infection. On day 0, the mice were anesthetized using an intraperitoneal injection of ketamine-xylazine (Syntec Brasil Ltd., S&#x00E3;o Paulo, Brazil) at 50 and 10 mg/kg, respectively, respectively. Uninfected, just administered cyclophosphamide and completely untreated cohorts (<italic>n</italic> = 10) served as the baseline controls [immunosuppressed only, uninfected group (control group)]. Subsequently, subcutaneous injections infected mice with 2 &#x00D7; 10&#x2227;4 zoospores/mouse (<xref ref-type="bibr" rid="B31">31</xref>). The infected mice were randomly divided into three groups, each comprising 10 animals. From day 0 (3 h after zoospore inoculation) to day 14 after infection, the mice received one of the following treatments: (i) oral Saline (PI group), (ii) oral AZM (50 mg/kg of body weight every 12 h; AZM group), (iii) oral DOX (40 mg/kg of body weight every 12 h; DOX group). The experimental process is shown in <xref ref-type="fig" rid="F2">Figure 2A</xref>. Throughout the study, the animals were monitored 3&#x2013;4 times daily for clinical signs such as changes in breathing, weight, mobility disorders, etc. Criteria for euthanizing the animals during the study included physical and mental alertness, chronic diarrhea, and bleeding. At the end of the experiment, all surviving animals were euthanized by deepening the anesthesia using thiopental (60 mg/kg). Histopathological analyses were performed. The number of hyphae in the tissue slices was measured using Gomori&#x2019;s methenamine silver (GMS) staining, which enabled the observation of <italic>P. insidiosum</italic> in the organs. Hematoxylin and eosin (H&#x0026;E) staining was used to identify inflammatory responses.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>Schematic representation of drug treatment for infected pythiosis animals <bold>(A)</bold>. Changes in infected wounds in animals of different treatment groups <bold>(B)</bold>. Survival of mice after treatment with control, AZM, DOX, and PI <bold>(C)</bold>, (<italic>n</italic> = 10). Results of H&#x0026;E staining of the liver, lung, spleen, and kidney in different treatment groups <bold>(D)</bold>. Results of tissue loading capacity tests using GMS staining on the kidneys, spleen, liver, and lungs of mice in different groups of treatment <bold>(E)</bold>. Scale bar: 100 &#x03BC;m. All data are presented as mean &#x00B1; SD, and significance was determined by one-way ANOVA (&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01, &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001). Control: immunosuppressed only (cyclophosphamide), uninfected; AZW, azithromycin; DOX, doxycycline; PI, saline.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1629018-g002.tif">
<alt-text content-type="machine-generated">Diagram showing a multi-step experimental timeline (A) of CYP treatment, zoospore injection, and assessment phases for drug treatments DOX, AZM, and PI in mice. Images of treated mice (B) display physical differences between control and drug groups. A survival probability graph (C) indicates varying survivorship over 30 days for each treatment. Histological images (D) detail spleen, kidney, liver, and lung tissues under various drug treatments, with notable differences observed. Additional histological slides (E) exhibit further organ tissue variances due to treatments, marked by visible arrows indicating significant changes.</alt-text>
</graphic>
</fig>
</sec>
<sec id="S2.SS8">
<label>2.8</label>
<title>Statistical analysis</title>
<p>Results were presented as means &#x00B1; standard deviation (SD). The statistical analysis was performed with GraphPad Prism (Version 8, United States). Unless otherwise specified, we used the unpaired <italic>t</italic>-test or one-way ANOVA to assess the statistical significance of comparisons (&#x002A;<italic>P</italic> &#x003C; 0.05, &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01, &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001, &#x002A;&#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.0001, ns: not significant).</p>
</sec>
</sec>
<sec id="S3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="S3.SS1">
<label>3.1</label>
<title>Epidemiological distribution of human pythiosis cases</title>
<p>Seventeen countries reported human pythiosis cases. The epidemiological distribution map revealed that human pythiosis cases maintained their predominant coastal distribution pattern across Asia and the Americas, with India and Thailand continuing to demonstrate the highest endemic burden (94.83% of total reported cases). The secondary prevalence clusters were China (<italic>n</italic> = 19) and the United States (<italic>n</italic> = 17), representing 1.75 and 1.57% of the global case load, respectively (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>Distribution world map of human pythiosis. The size of the circles represents the number of cases in each region and yellow areas were the regions with reported cases. The legend in the lower right corner indicates the specific case counts.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1629018-g003.tif">
<alt-text content-type="machine-generated">World map with colored pie charts representing data points for different countries. The chart sizes and colors vary, showing distribution of data across nations like Australia, China, India, USA, and others. A legend on the right matches colors to countries for clarity.</alt-text>
</graphic>
</fig>
</sec>
<sec id="S3.SS2">
<label>3.2</label>
<title>Isolation and identification of <italic>P. insidiosum</italic></title>
<p>Based on its microscopic features and phylogenetic analysis, the isolate was identified as a Pythium species. At 37 &#x00B0;C, <italic>P. insidiosum</italic> was characterized by white, sunflower-shaped, radiating colonies on brain heart infusion agar (<xref ref-type="fig" rid="F4">Figure 4A</xref>) and submerged, white to colorless colonies with an irregular radiate pattern on Sabouraud agar (<xref ref-type="fig" rid="F4">Figure 4B</xref>). The hyphae of <italic>P. insidiosum</italic> had lateral branches with diameters ranging from 4 to 10 &#x03BC;m. Older hyphae usually showed transverse septa, with protoplasmic nutrients flowing inside the hyphae (<xref ref-type="fig" rid="F4">Figure 4C</xref>). Next, we conducted zoospore reproduction and SEM and TEM analyses of <italic>P. insidiosum</italic>. Zoospore release can be observed through microscopy (<xref ref-type="fig" rid="F5">Figures 5</xref>, <xref ref-type="fig" rid="F6">6</xref>; <xref ref-type="supplementary-material" rid="VS1">Supplementary Video 1</xref>), and the process took about 35 min. The zoospores broke the vesicle wall and swam for approximately 20 min, eventually losing their flagella when they became resting spores (<xref ref-type="fig" rid="F6">Figures 6D&#x2013;F</xref>). When external conditions are suitable, the zoospores re-sprout to form hyphae (<xref ref-type="fig" rid="F6">Figures 6G&#x2013;I</xref>). In addition, the flow of protoplasm within the hypha was found (<xref ref-type="supplementary-material" rid="VS2">Supplementary Video 2</xref>). Traditional sporulation methods yield a small number of spores that are difficult to recover. In contrast, the improved method produced more spores that could be easily recovered and utilized. The spore yield of our improved method was 250 times that of the traditional method in shorter periods (<xref ref-type="fig" rid="F1">Figures 1B&#x2013;D</xref>; <xref ref-type="supplementary-material" rid="DS2">Supplementary Data Sheet 2</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>Culture morphology in different mediums and sequence construction cluster analysis tree of <italic>P. insidiosum</italic>. Culture morphology on brain heart infusion agar, and sabouraud dextrose agar <bold>(A,B)</bold>. Microscopic observation of the hyphae morphology of <italic>P. insidiosum</italic> <bold>(C)</bold>. LSU <bold>(D)</bold> and COI <bold>(E)</bold> sequence showed that the isolated strain was on the same branch as <italic>P. insidiosum</italic> CBS 574.85.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1629018-g004.tif">
<alt-text content-type="machine-generated">Five images labeled A to E. A: A Petri dish with a radial fungal growth pattern. B: A Petri dish with more prominent fungal growth. C: Microscopic view of fungal structures with a scale of 100 micrometers. D: Phylogenetic tree of Pythium species based on LSU sequences. E: Phylogenetic tree of Pythium species based on COI sequences, highlighting P. insidiosum.</alt-text>
</graphic>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p>The process of zoospore release from <italic>P. insidiosum</italic> vesicles. The electron photographs showed globose vesicles leading to the release of secondary-type zoospores <bold>(A&#x2013;I)</bold>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1629018-g005.tif">
<alt-text content-type="machine-generated">A series of nine microscopic images labeled A to I, showing progressive stages of fungal or microbial growth against a gray background. The structure appears clustered, with each image depicting subtle changes in arrangement or size. The images are arranged in a grid, with incremental changes between each frame. A scale bar is present in the bottom right corner of the last image, labeled G.</alt-text>
</graphic>
</fig>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption><p>Scanning electron microscopy of <italic>P. insidiosum at</italic> different stages of development. Hyphae <bold>(A)</bold>. Sporangium <bold>(B)</bold>. Globose vesicles <bold>(C)</bold>. Spores <bold>(D&#x2013;F)</bold>. Zoospores germinate into hyphae <bold>(G&#x2013;I)</bold>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1629018-g006.tif">
<alt-text content-type="machine-generated">Scanning electron micrographs display various fungal structures with spherical spores and branching hyphae. Each image, labeled A through I, shows different magnifications and arrangements of the intertwined structures. Scale bars indicate the size, ranging from 4 to 10 micrometers, highlighting the intricate details and textures of the fungal components.</alt-text>
</graphic>
</fig>
<p>The mitochondrial gene COI and the nuclear ribosomal gene LSU are frequently applied in phylogenetic analysis, species identification, and the exploration of evolutionary history. According to the BLAST results from the NCBI database, the COI and LSU gene amplification primer sequences shared a 100.00% sequence identity with <italic>P. insidiosum</italic> CBS 574.85 (<xref ref-type="fig" rid="F4">Figure 4</xref>). The sequences of <italic>P. insidiosum</italic> were obtained through homology searches in the GenBank database. Phylogenetic analysis indicated that <italic>the P. insidiosum</italic> isolate in this study was genetically closely related to <italic>the P. insidiosum</italic> isolate from Costa Rica.</p>
</sec>
<sec id="S3.SS3">
<label>3.3</label>
<title>The inner structure of <italic>P. insidiosum</italic> with TEM</title>
<p><italic>P. insidiosum</italic> has a distinct cell wall consisting of several inner layers and typical internal organelles. The cell wall has a smooth plasma membrane (cytoplasmic membrane) associated with interlaced and meshed inner layers that form coarse and thick inner layers (<xref ref-type="fig" rid="F7">Figure 7</xref>). Cytoplasmic vesicles are transported from the cytosolic compartment to the plasma membrane and integrated into the inner layer. Once integrated, the cytoplasmic bilayer membrane maintains its structural integrity. Large vacuoles containing black electron-dense bodies (EDBs) were observed within the cytosolic compartment. Some fields of the microscope of our sample showed nuclei, each surrounded by a bilayer membrane and containing granular chromatin (<xref ref-type="fig" rid="F7">Figures 7A,D</xref>). Golgi structures with numerous Golgi vesicles pinching off from the Golgi apparatus were also detected in the hyphae. Golgi vesicles were found to integrate into the plasmalemma surrounding the cell wall. There were relatively large microtubules dispersed throughout the hyphae. Endoplasmic reticula (ER) were sometimes detected near the mitochondria, with multiple ribosomes around the ER. Numerous small vacuoles with fine granular contents, which varied in size and shape, were dispersed throughout the hyphae. Some stained samples contained numerous mitochondria with tubular cristae.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption><p>Details low magnification views of two different laterally sectioned <italic>P. insidiosum</italic> under TEM. All the structures are marked with arrows in the image. CW, cell walls; EDB, electron-dense black body; ER, endoplasmic reticulum; G, Golgi apparatus; GV, Golgi vesicles; IL, inner layers; LV, large vesicles; MT, microtubules; N, nuclei; R, ribosomes; SV, small vesicles.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1629018-g007.tif">
<alt-text content-type="machine-generated">Electron micrographs of six different protist cells labeled A to F. Each micrograph shows various cellular structures such as nucleus (N), food vacuole (FV), mitochondrion (MT), cytoplasm (CY), and other organelles. The cells vary in shape and size, with labels indicating specific features like the cell wall (CW), inner cell structures, and vacuoles. Scale bars are included for reference ranging from 600 nanometers to 6 micrometers.</alt-text>
</graphic>
</fig>
</sec>
<sec id="S3.SS4">
<label>3.4</label>
<title>Drug sensitivity <italic>in vitro</italic></title>
<p>To evaluate the effectiveness of existing antibiotics and antifungals against <italic>P. insidiosum</italic>, we conducted drug sensitivity tests <italic>in vitro</italic>. Our results showed that <italic>P. insidiosum</italic> was more sensitive to antibiotics than to antifungal agents. The MIC values of antibiotics against <italic>P. insidiosum</italic> were significantly lower than those of the antifungals (<xref ref-type="table" rid="T1">Table 1</xref>). Notably, DOX and AZM exhibited effective results against <italic>P. insidiosum</italic>. The MIC values for DOX and AZM were 4 &#x03BC;g/mL and 8 &#x03BC;g/mL, respectively. Other antibiotics, such as TIG, TET, CHL, and LZD, also showed varying effectiveness. In contrast, antifungal drugs such as fluorocytosine, amphotericin B, itraconazole, and fluconazole had much higher MIC values (higher than 128 ug/mL, indicating lower effectiveness. However, SMZ/TMP had a MIC value of 375 &#x03BC;g/ml. These results highlight the potential of using antibiotics, particularly DOX and AZM, to treat the infections caused by <italic>P. insidiosum</italic>.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Susceptibility results for antimicrobial drugs against <italic>P. insidiosum in vitro.</italic></p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<th valign="top" align="left">Antimicrobial class</th>
<th valign="top" align="left">Drug</th>
<th valign="top" align="left">MIC (&#x03BC;g/mL)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="4">Antifungal drugs</td>
<td valign="top" align="left">Fluorocytosine</td>
<td valign="top" align="left">256</td>
</tr>
<tr>
<td valign="top" align="left">Amphotericin B</td>
<td valign="top" align="left">128</td>
</tr>
<tr>
<td valign="top" align="left">Itraconazole</td>
<td valign="top" align="left">&#x003E; 256</td>
</tr>
<tr>
<td valign="top" align="left">Fluconazole</td>
<td valign="top" align="left">256</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="10">Antibiotic</td>
<td valign="top" align="left">Doxycycline (DOX)</td>
<td valign="top" align="left">4</td>
</tr>
<tr>
<td valign="top" align="left">Tigecycline (TIG)</td>
<td valign="top" align="left">2</td>
</tr>
<tr>
<td valign="top" align="left">Tetracycline (TET)</td>
<td valign="top" align="left">4</td>
</tr>
<tr>
<td valign="top" align="left">Chloramphenicol (CHL)</td>
<td valign="top" align="left">16</td>
</tr>
<tr>
<td valign="top" align="left">Linezolid (LZD)</td>
<td valign="top" align="left">16</td>
</tr>
<tr>
<td valign="top" align="left">Erythromycin (ERY)</td>
<td valign="top" align="left">8</td>
</tr>
<tr>
<td valign="top" align="left">Azithromycin (AZM)</td>
<td valign="top" align="left">8</td>
</tr>
<tr>
<td valign="top" align="left">Gentamicin (GEN)</td>
<td valign="top" align="left">&#x003E; 256</td>
</tr>
<tr>
<td valign="top" align="left">Florfenicol (FFC)</td>
<td valign="top" align="left">4</td>
</tr>
<tr>
<td valign="top" align="left">SMZ/TMP</td>
<td valign="top" align="left">375</td>
</tr>
</tbody>
</table></table-wrap>
</sec>
<sec id="S3.SS5">
<label>3.5</label>
<title>Drug sensitivity <italic>in vivo</italic></title>
<p>To certify the drug sensitivity results <italic>in vitro</italic>, we conducted the drug sensitivity <italic>in vivo</italic>. The mice in the PI group appeared to have coarse and disheveled fur, were listless, and had a dull response to stimulation after inoculation with zoospores 48 h. In contrast, those in the AZM and DOX groups appeared to have a more lustrous coat, were more vigorous, and were more alert to external stimuli during the entire observation period. One week after inoculation with zoospores, surviving mice in all groups exhibited hair loss and skin ulceration at the injection sites. Ulcerated lesions were observed at the inoculation site in mice infected with <italic>P. insidiosum</italic> (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Forty eight hours after inoculation with zoospores, the PI group showed mortality, while no deaths were observed in the control, AZM, and DOX groups. All deaths occurred within the first 5 days in the PI group, whereas the fewer deaths in the DOX and AZM groups were delayed 3&#x2013;9 days. AZM and DOX treatments were more effective in promoting wound healing than the PI group (<xref ref-type="fig" rid="F2">Figure 2B</xref>). The control and PI groups exhibited survival rates of 100 and 20%, respectively. In contrast, the AZM and DOX treatment groups had 80 and 90% survival rates, respectively. AZM and DOX significantly reduced mortality compared to the saline group, the AZM group showing a 3-fold reduction and the DOX group showing a 3.5-fold reduction in mortality (<italic>P</italic> = 0.0056 for AZM, <italic>P</italic> = 0.0008 for DOX) (<xref ref-type="fig" rid="F2">Figure 2C</xref>; <xref ref-type="supplementary-material" rid="DS3">Supplementary Data Sheet 3</xref>). Next, to further confirm the drug effects <italic>in vivo</italic>, we conducted a detection of <italic>P. insidiosum</italic> load in the kidneys, spleen, liver, and lungs of BALB/c mice (AZM, DOX, PI groups) that were subcutaneously infected with <italic>P. insidiosum</italic> (<xref ref-type="fig" rid="F2">Figure 2E</xref>). Microbiological organ cultures revealed that 80% of the infected mice in the PI-treated group had established <italic>P. insidiosum</italic> infections in the liver. In the PI group, Histological H&#x0026;E staining revealed prominent neutrophilic periarteritis with thrombosis and perivascular inflammatory infiltration in the liver, lung, spleen, and kidney of mice (<xref ref-type="fig" rid="F2">Figure 2D</xref>). In contrast, the histological features of the mice in the AZM and DOX treatment groups were improved compared to those in the PI group, indicating the therapeutic effects of AZM and DOX on pythiosis. GMS staining revealed fewer positively stained <italic>P. insidiosum</italic> cells in the tissues off mice in the AZM and DOX treatment groups. GMS staining of the PI group demonstrated a higher presence of black-dyed hyphae in the liver, while no hyphae were observed in other organs (<xref ref-type="fig" rid="F2">Figure 2E</xref>). In contrast, GMS staining of tissues from mice treated with AZM and DOX showed no black-dyed hyphae, suggesting a significant reduction in <italic>P. insidiosum</italic> burden. Thus, treatment with the antibiotics AZM and DOX resulted in marked improvement in histological lesions and a substantial decrease in <italic>P. insidiosum</italic> load <italic>in vivo</italic>.</p>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Pythiosis is a severe disease with high morbidity and mortality, particularly in patients with disseminated infections or vascular diseases (<xref ref-type="bibr" rid="B6">6</xref>). The recent reports of pythiosis in humans are gradually increasing and require more attention. Our epidemic distribution map data reaffirmed Asia&#x2019;s disproportionate pythiosis burden, with 94.83% of global cases concentrated in India and Thailand. Notably, China&#x2019;s 1.75% case contribution calls for heightened vigilance. Frontline clinicians in ophthalmology, dermatology, and infectious diseases must pay more attention to pythiosis, which has been reported in 17 countries. The systematic synthesis of historical case data distribution enables healthcare providers to rapidly assimilate critical diagnostic biomarkers and effective intervention strategies for suspected cases, thereby reducing the time-to-diagnosis and improving the survival rate.</p>
<p>The cultivation-based approach remains one of the most important methods and provides additional advantages for susceptibility testing for <italic>P. insidiosum</italic>. Identifying <italic>P. insidiosum</italic> based on morphology alone is challenging and insufficient because of the restricted morphological differentiation in culture (<xref ref-type="bibr" rid="B32">32</xref>). Direct sample multiplex-PCR, a potential tool for rapid equine pythiosis diagnosis, overcomes morphological identification limitations and provides a definitive diagnosis (<xref ref-type="bibr" rid="B33">33</xref>). Molecular phylogenetic analysis is a reliable method for identifying <italic>P. insidiosum</italic> using COX and LSU (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Our results suggest that the isolate is more closely related to <italic>P. insidiosum</italic> than to any other Pythium species, indicating that it is the same species. This improves the accuracy and dependability of our subsequent findings. The novel sporulation protocol developed here addresses longstanding cultivation challenges based on the improvements made in earlier studies (<xref ref-type="bibr" rid="B24">24</xref>). Although molecular assays are increasingly employed, conventional culture followed by zoospore induction is still regarded as the gold standard (<xref ref-type="bibr" rid="B14">14</xref>). We combined an induction liquid and Annona Squamosa L. leaf extract, which significantly increased zoospore production compared to existing techniques. This was a critical advancement in the research on the biological characteristics of <italic>P. insidiosum</italic>. Traditional methods often involve complex and time-consuming procedures. The traditional method requires nearly 27 h to induce enough zoospores, while ours requires 10&#x2013;24 h, and the number of zoospores produced using our modified method was 250 times that of the traditional method. Our modified method streamlines these steps, making the process more efficient and accessible to researchers. Our modified method may be a step forward in microbiology, specifically in oomycetes, and potentially accelerate the development of new treatments or preventive measures against pythiosis. In conclusion, the modified method for inducing sporulation in <italic>P. insidiosum</italic> was more efficient, time-saving, and simplified than the traditional methods.</p>
<p>To better understand the life cycle and the internal morphological and structural characteristics of <italic>P. insidiosum</italic>, we used TEM and SEM to elucidate the dynamic changes in <italic>P. insidiosum</italic> from hyphae to zoospores and examine its internal cellular structure with TEM. Our observations reveal several key ultrastructural features of <italic>P. insidiosum</italic> hyphae and zoospore, including the cell wall, inner layers, vesicular transport system, and other organelles. These detailed structural insights provided a foundation for understanding the organization and function of <italic>P. insidiosum</italic> at the cellular level. The detailed visualization of <italic>P. insidiosum&#x2019;</italic>s cellular structures via TEM, including its cell wall and antigen distribution mapped through immuno-electron microscopy, provides a foundation for understanding its pathogenesis and suggests potential targets for diagnostic and therapeutic interventions (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). Therefore, understanding these structural features is essential for identifying potential targets for developing new antimicrobial agents.</p>
<p>The treatment of pythiosis has seen considerable advancements; however, it remains a complex challenge. Tetracyclines, macrolides, aminoglycosides, and other antibiotics (such as LZD, nitrofurantoin, quinupristin-dalfopristin, CHL, clindamycin, and mupirocin) have demonstrated inhibitory activity against <italic>P. insidiosum in vitro</italic> (<xref ref-type="bibr" rid="B20">20</xref>). Our results <italic>in vitro</italic> showed that <italic>P. insidiosum</italic> was more susceptible to antibiotics than antifungal medications. This conclusion is similar to the previous study, which found that antibiotics inhibit <italic>P. insidiosum</italic> 100 times more than antifungal agents (<xref ref-type="bibr" rid="B37">37</xref>). Tetracyclines and macrolides may also be potential candidates for infection control, consistent with these studies (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). <italic>In vitro</italic> drug sensitivity tests showed that sulfamethoxazole had no bacteriostatic effect. However, the patient with the isolated strain of P. insidiosum was cured with a multi-drug plan containing SMZ/TMP and antifungal drugs, with SMZ/TMP as the only drug at the end. This efficacy discrepancy between <italic>in vitro</italic> and <italic>in vivo</italic> is not uncommon and can be attributed to several factors. Firstly, the metabolic state of <italic>P. insidiosum</italic> can change <italic>in vivo</italic>, which may influence its susceptibility to drugs (<xref ref-type="bibr" rid="B39">39</xref>). <italic>P. insidiosum</italic> can develop mutations of the dihydropteroate synthase gene <italic>in vivo</italic>, which is the target of SMZ/TMP, and change the drug sensitivity. Secondly, SMZ/TMP has been shown to trigger allergic reactions and enhance immune function which inhibit the growth of melanoma skin cancer (<xref ref-type="bibr" rid="B40">40</xref>). Therefore, it is plausible that SMZ/TMP may enhance the host immune system to exhibit anti-<italic>P. insidiosum</italic> effect. However, further investigation is needed to validate these mechanisms.</p>
<p>Drug sensitivity experiments conducted <italic>in vivo</italic> have indicated that DOX and AZM are the main antibiotics used to treat pythiosis (<xref ref-type="bibr" rid="B41">41</xref>). Our mouse model successfully mimicked vascular/spread pythiosis in humans, demonstrating systemic illness following subcutaneous injection of <italic>P. insidiosum</italic> (<xref ref-type="bibr" rid="B25">25</xref>). Investigations <italic>in vivo</italic> corroborating our <italic>in vitro</italic> findings indicated that AZM and DOX alone showed positive therapeutic effects in the treatment of pythiosis in mice. Both medications significantly improved histological changes and survival rates (<italic>P</italic> &#x003C; 0.05) and reduced the fungal load in the liver, echoing the results of previous studies (<xref ref-type="bibr" rid="B42">42</xref>&#x2013;<xref ref-type="bibr" rid="B44">44</xref>). Our results further confirm that mice are a reliable model for <italic>P. insidiosum</italic> infection, and we recommend their use in future studies. However, our study was limited to a single <italic>P. insidiosum</italic> strain, and the mechanisms of action of AZM and DOX against <italic>P. insidiosum</italic> remain elusive, possibly involving the inhibition of protein synthesis, cell wall synthesis, and/or amino acid transport (<xref ref-type="bibr" rid="B43">43</xref>). In China, where infection rates are low but increasing, it is essential to analyze data on this strain thoroughly to develop effective treatments for the disease.</p>
</sec>
<sec id="S5" sec-type="conclusion">
<label>5</label>
<title>Conclusion</title>
<p>Epidemiological investigations have revealed that India and Thailand are hotspots for human pythiosis, and sporadic cases are increasing in China, the Americas, and Europe. We performed comprehensive tests, including molecular biology, morphology, and biological processes, to confirm that this strain was <italic>P. insidiosum</italic>. We developed a modified spore-producing method and showed the microstructures with TEM, which may benefit future studies on <italic>P. insidiosum</italic>. Finally, through drug susceptibility testing <italic>in vitro</italic> and <italic>in vivo</italic>, we successfully reconfirmed effective drugs for pythiosis, which will provide theoretical and technical support for the rapid diagnosis and treatment of outbreaks of such diseases in inexperienced areas with few epidemics. We recommend that AZM and DOX be considered in future <italic>in vivo</italic> experimental studies evaluating the treatment of pythiosis.</p>
</sec>
<sec id="S6">
<label>6</label>
<title>Limitations of the study</title>
<p>The epidemic distribution depends on the reported data, which would not be very accurate for some cases that are not reported. The limited number of isolates tested and the specific dosages and durations required for drug combination experiments have not yet been explored. We have also not conducted further studies on the mechanism of its therapeutic effect. Thus, further research, including a more significant number of isolates, especially from genetically diverse <italic>P. insidiosum</italic> strains, different drug regimen treatments, and associations with other antimicrobials, immunotherapies, and surgery, will provide a better understanding of the therapeutic potential of AZM and DOX in pythiosis treatment, as well as the pathogenesis of <italic>P. insidiosum</italic> infection in humans and animals. Our efforts should also include elucidating the exact mechanisms of effective sulfanilamide in our patients.</p>
</sec>
</body>
<back>
<sec id="S7" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="FS1">Supplementary material</xref>, further inquiries can be directed to the corresponding author/s.</p>
</sec>
<sec id="S8" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal experimental procedures were approved by the SCAU Institutional Ethics Committee. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="S9" sec-type="author-contributions">
<title>Author contributions</title>
<p>XL: Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. QD: Formal analysis, Investigation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. ML: Writing &#x2013; review &#x0026; editing. YY: Methodology, Writing &#x2013; review &#x0026; editing. JL: Formal analysis, Investigation, Writing &#x2013; review &#x0026; editing. ZC: Methodology, Writing &#x2013; review &#x0026; editing. HZ: Formal analysis, Investigation, Writing &#x2013; review &#x0026; editing. HH: Formal analysis, Investigation, Writing &#x2013; review &#x0026; editing. JH: Methodology, Writing &#x2013; review &#x0026; editing. HR: Formal analysis, Investigation, Writing &#x2013; review &#x0026; editing. FZ: Writing &#x2013; review &#x0026; editing. TS: Methodology, Writing &#x2013; review &#x0026; editing. XLia: Methodology, Writing &#x2013; review &#x0026; editing. JS: Conceptualization, Funding acquisition, Writing &#x2013; review &#x0026; editing. KZ: Conceptualization, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>The authors thank Jiahao Zhang (College of Veterinary Medicine, South China Agricultural University) for his assistance in disease burden mapping and manuscript revision.</p>
</ack>
<sec id="S11" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="S12" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The authors declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="S13" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="S14" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmed.2025.1629018/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmed.2025.1629018/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image_1.pdf" id="FS1" mimetype="application/pdf"/>
<supplementary-material xlink:href="Video_1.avi" id="VS1" mimetype="video/avi"/>
<supplementary-material xlink:href="Video_2.mp4" id="VS2" mimetype="video/mp4"/>
<supplementary-material xlink:href="Data_Sheet_1.xlsx" id="DS1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Data_Sheet_2.xlsx" id="DS2" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Data_Sheet_3.xlsx" id="DS3" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaastra</surname> <given-names>W</given-names></name> <name><surname>Lipman</surname> <given-names>LJA</given-names></name> <name><surname>De Cock</surname> <given-names>AWAM</given-names></name> <name><surname>Exel</surname> <given-names>TK</given-names></name> <name><surname>Pegge</surname> <given-names>RBG</given-names></name> <name><surname>Scheurwater</surname> <given-names>J</given-names></name><etal/></person-group> <article-title><italic>Pythium insidiosum</italic>: an overview.</article-title> <source><italic>Vet Microbiol.</italic></source> (<year>2010</year>) <volume>146</volume>:<fpage>1</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetmic.2010.07.019</pub-id> <pub-id pub-id-type="pmid">20800978</pub-id></mixed-citation></ref>
<ref id="B2">
<label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Ran</surname> <given-names>Y</given-names></name> <name><surname>Jia</surname> <given-names>S</given-names></name> <name><surname>Ahmed</surname> <given-names>S</given-names></name> <name><surname>Long</surname> <given-names>X</given-names></name> <name><surname>Jiang</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Human disseminated protothecosis: The skin is the &#x201C;window&#x201D;?</article-title> <source><italic>Front Immunol.</italic></source> (<year>2022</year>) <volume>13</volume>:<fpage>880196</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2022.880196</pub-id> <pub-id pub-id-type="pmid">35774787</pub-id></mixed-citation></ref>
<ref id="B3">
<label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arias</surname> <given-names>AF</given-names></name> <name><surname>Romero</surname> <given-names>SD</given-names></name> <name><surname>Garc&#x00E9;s</surname> <given-names>CG</given-names></name></person-group>. <article-title>Case report: Rhinosporidiosis literature review.</article-title> <source><italic>Am J Trop Med Hyg.</italic></source> (<year>2020</year>) <volume>104</volume>:<fpage>708</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.20-0291</pub-id> <pub-id pub-id-type="pmid">33289469</pub-id></mixed-citation></ref>
<ref id="B4">
<label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza</surname> <given-names>L</given-names></name> <name><surname>Taylor</surname> <given-names>JW</given-names></name> <name><surname>Walker, Vilela</surname> <given-names>R</given-names></name></person-group>. <article-title>Description of three novel Lagenidium (Oomycota) species causing infection in mammals.</article-title> <source><italic>Rev Iberoam Micol.</italic></source> (<year>2016</year>) <volume>33</volume>:<fpage>83</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.riam.2015.07.005</pub-id> <pub-id pub-id-type="pmid">26924580</pub-id></mixed-citation></ref>
<ref id="B5">
<label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza</surname> <given-names>L</given-names></name> <name><surname>Newton</surname> <given-names>JC</given-names></name></person-group>. <article-title>Immunology and immunotherapy of the infections caused by <italic>Pythium insidiosum</italic>.</article-title> <source><italic>Med Mycol.</italic></source> (<year>2005</year>) <volume>43</volume>:<fpage>477</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1080/13693780500279882</pub-id> <pub-id pub-id-type="pmid">16320491</pub-id></mixed-citation></ref>
<ref id="B6">
<label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krajaejun</surname> <given-names>T</given-names></name> <name><surname>Sathapatayavongs</surname> <given-names>B</given-names></name> <name><surname>Pracharktam</surname> <given-names>R</given-names></name> <name><surname>Nitiyanant</surname> <given-names>P</given-names></name> <name><surname>Leelachaikul</surname> <given-names>P</given-names></name> <name><surname>Wanachiwanawin</surname> <given-names>W</given-names></name><etal/></person-group> <article-title>Clinical and epidemiological analyses of human pythiosis in thailand.</article-title> <source><italic>Clin Infect Dis Off Publ Infect Dis Soc Am.</italic></source> (<year>2006</year>) <volume>43</volume>:<fpage>569</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1086/506353</pub-id> <pub-id pub-id-type="pmid">16886148</pub-id></mixed-citation></ref>
<ref id="B7">
<label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudjaritruk</surname> <given-names>T</given-names></name> <name><surname>Sirisanthana</surname> <given-names>V</given-names></name></person-group>. <article-title>Successful treatment of a child with vascular pythiosis.</article-title> <source><italic>BMC Infect Dis.</italic></source> (<year>2011</year>) <volume>11</volume>:<fpage>33</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-11-33</pub-id> <pub-id pub-id-type="pmid">21276255</pub-id></mixed-citation></ref>
<ref id="B8">
<label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza</surname> <given-names>L</given-names></name> <name><surname>Hernandez</surname> <given-names>F</given-names></name> <name><surname>Ajello</surname> <given-names>L</given-names></name></person-group>. <article-title>Life cycle of the human and animal oomycete pathogen <italic>Pythium insidiosum</italic>.</article-title> <source><italic>J Clin Microbiol.</italic></source> (<year>1993</year>) <volume>31</volume>:<fpage>2967</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1128/jcm.31.11.2967-2973.1993</pub-id> <pub-id pub-id-type="pmid">8263182</pub-id></mixed-citation></ref>
<ref id="B9">
<label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Es</surname> <given-names>L</given-names></name> <name><surname>Jsm</surname> <given-names>T</given-names></name> <name><surname>Ra</surname> <given-names>Z</given-names></name></person-group>. <article-title>Treating pythiosis with antibacterial drugs targeting protein synthesis: an overview.</article-title> <source><italic>J Fungi Basel Switz.</italic></source> (<year>2024</year>) <volume>10</volume>:<fpage>234</fpage>. <pub-id pub-id-type="doi">10.3390/jof10040234</pub-id> <pub-id pub-id-type="pmid">38667905</pub-id></mixed-citation></ref>
<ref id="B10">
<label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chitasombat</surname> <given-names>MN</given-names></name> <name><surname>Jongkhajornpong</surname> <given-names>P</given-names></name> <name><surname>Lekhanont</surname> <given-names>K</given-names></name> <name><surname>Krajaejun</surname> <given-names>T</given-names></name></person-group>. <article-title>Recent update in diagnosis and treatment of human pythiosis.</article-title> <source><italic>PeerJ.</italic></source> (<year>2020</year>) <volume>8</volume>:<fpage>e8555</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.8555</pub-id> <pub-id pub-id-type="pmid">32117626</pub-id></mixed-citation></ref>
<ref id="B11">
<label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues Hoffmann</surname> <given-names>A</given-names></name> <name><surname>Ramos</surname> <given-names>MG</given-names></name> <name><surname>Walker</surname> <given-names>RT</given-names></name> <name><surname>Stranahan</surname> <given-names>LW</given-names></name></person-group>. <article-title>Hyphae, pseudohyphae, yeasts, spherules, spores, and more: a review on the morphology and pathology of fungal and oomycete infections in the skin of domestic animals.</article-title> <source><italic>Vet Pathol.</italic></source> (<year>2023</year>) <volume>60</volume>:<fpage>812</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1177/03009858231173715</pub-id> <pub-id pub-id-type="pmid">37222139</pub-id></mixed-citation></ref>
<ref id="B12">
<label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robideau</surname> <given-names>GP</given-names></name> <name><surname>De Cock</surname> <given-names>AWAM</given-names></name> <name><surname>Coffey</surname> <given-names>MD</given-names></name> <name><surname>Voglmayr</surname> <given-names>H</given-names></name> <name><surname>Brouwer</surname> <given-names>H</given-names></name> <name><surname>Bala</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>DNA barcoding of oomycetes with cytochrome c oxidase subunit I and internal transcribed spacer.</article-title> <source><italic>Mol Ecol Resour.</italic></source> (<year>2011</year>) <volume>11</volume>:<fpage>1002</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1111/j.1755-0998.2011.03041.x</pub-id> <pub-id pub-id-type="pmid">21689384</pub-id></mixed-citation></ref>
<ref id="B13">
<label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Godoy Macedo</surname> <given-names>PL</given-names></name> <name><surname>Taborda</surname> <given-names>M</given-names></name> <name><surname>de Oliveira</surname> <given-names>VF</given-names></name> <name><surname>Magri</surname> <given-names>ASGK</given-names></name> <name><surname>Frutuoso</surname> <given-names>LL</given-names></name> <name><surname>de Oliveira</surname> <given-names>GM</given-names></name><etal/></person-group> <article-title>Brazilian task force for the management of mucormycosis.</article-title> <source><italic>Braz J Infect Dis Off Publ Braz Soc Infect Dis.</italic></source> (<year>2025</year>) <volume>29</volume>:<fpage>104579</fpage>. <pub-id pub-id-type="doi">10.1016/j.bjid.2025.104579</pub-id> <pub-id pub-id-type="pmid">40974632</pub-id></mixed-citation></ref>
<ref id="B14">
<label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>L</given-names></name> <name><surname>Huang</surname> <given-names>X</given-names></name> <name><surname>Yee</surname> <given-names>NH</given-names></name> <name><surname>Meng</surname> <given-names>H</given-names></name> <name><surname>Jiang</surname> <given-names>L</given-names></name> <name><surname>Liang</surname> <given-names>L</given-names></name><etal/></person-group> <article-title><italic>Pythium insidiosum</italic>: an emerging pathogen that is easily misdiagnosed and given treatment as a fungus.</article-title> <source><italic>Front Cell Infect Microbiol.</italic></source> (<year>2024</year>) <volume>14</volume>:<fpage>1430032</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2024.1430032</pub-id> <pub-id pub-id-type="pmid">39268488</pub-id></mixed-citation></ref>
<ref id="B15">
<label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salipante</surname> <given-names>SJ</given-names></name> <name><surname>Hoogestraat</surname> <given-names>DR</given-names></name> <name><surname>SenGupta</surname> <given-names>DJ</given-names></name> <name><surname>Murphey</surname> <given-names>D</given-names></name> <name><surname>Panayides</surname> <given-names>K</given-names></name> <name><surname>Hamilton</surname> <given-names>E</given-names></name><etal/></person-group> <article-title>Molecular diagnosis of subcutaneous <italic>Pythium insidiosum</italic> infection by use of PCR screening and DNA sequencing.</article-title> <source><italic>J Clin Microbiol.</italic></source> (<year>2012</year>) <volume>50</volume>:<fpage>1480</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.06126-11</pub-id> <pub-id pub-id-type="pmid">22205808</pub-id></mixed-citation></ref>
<ref id="B16">
<label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H</given-names></name> <name><surname>Zhou</surname> <given-names>F</given-names></name> <name><surname>Huang</surname> <given-names>J</given-names></name> <name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Xu</surname> <given-names>H</given-names></name> <name><surname>Liang</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Severe skin and subcutaneous pythiosis in China: Metagenomic identification and characterization of <italic>Pythium insidiosum</italic>.</article-title> <source><italic>Front Microbiol.</italic></source> (<year>2022</year>) <volume>13</volume>:<fpage>1002460</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2022.1002460</pub-id> <pub-id pub-id-type="pmid">36246283</pub-id></mixed-citation></ref>
<ref id="B17">
<label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yolanda</surname> <given-names>H</given-names></name> <name><surname>Krajaejun</surname> <given-names>T</given-names></name></person-group>. <article-title>Global distribution and clinical features of pythiosis in humans and animals.</article-title> <source><italic>J Fungi Basel Switz.</italic></source> (<year>2022</year>) <volume>8</volume>:<fpage>182</fpage>. <pub-id pub-id-type="doi">10.3390/jof8020182</pub-id> <pub-id pub-id-type="pmid">35205934</pub-id></mixed-citation></ref>
<ref id="B18">
<label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yolanda</surname> <given-names>H</given-names></name> <name><surname>Krajaejun</surname> <given-names>T</given-names></name></person-group>. <article-title>Review of methods and antimicrobial agents for susceptibility testing against <italic>Pythium insidiosum</italic>.</article-title> <source><italic>Heliyon.</italic></source> (<year>2020</year>) <volume>6</volume>:<fpage>e03737</fpage>. <pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e03737</pub-id> <pub-id pub-id-type="pmid">32322727</pub-id></mixed-citation></ref>
<ref id="B19">
<label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yolanda</surname> <given-names>H</given-names></name> <name><surname>Krajaejun</surname> <given-names>T</given-names></name></person-group>. <article-title>History and perspective of immunotherapy for pythiosis.</article-title> <source><italic>Vaccines.</italic></source> (<year>2021</year>) <volume>9</volume>:<fpage>1080</fpage>. <pub-id pub-id-type="doi">10.3390/vaccines9101080</pub-id> <pub-id pub-id-type="pmid">34696188</pub-id></mixed-citation></ref>
<ref id="B20">
<label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medhasi</surname> <given-names>S</given-names></name> <name><surname>Chindamporn</surname> <given-names>A</given-names></name> <name><surname>Worasilchai</surname> <given-names>N</given-names></name></person-group>. <article-title>A review: Antimicrobial therapy for human pythiosis.</article-title> <source><italic>Antibiot Basel Switz.</italic></source> (<year>2022</year>) <volume>11</volume>:<fpage>450</fpage>. <pub-id pub-id-type="doi">10.3390/antibiotics11040450</pub-id> <pub-id pub-id-type="pmid">35453202</pub-id></mixed-citation></ref>
<ref id="B21">
<label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>H</given-names></name> <name><surname>Liu</surname> <given-names>H</given-names></name> <name><surname>Chen</surname> <given-names>X</given-names></name> <name><surname>Wu</surname> <given-names>J</given-names></name> <name><surname>He</surname> <given-names>M</given-names></name> <name><surname>Zhong</surname> <given-names>X</given-names></name></person-group>. <article-title>Diagnosis and treatment of <italic>Pythium insidiosum</italic> corneal ulcer in a Chinese child: a case report and literature review.</article-title> <source><italic>Am J Case Rep.</italic></source> (<year>2016</year>) <volume>17</volume>:<fpage>982</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.12659/ajcr.901158</pub-id> <pub-id pub-id-type="pmid">28025573</pub-id></mixed-citation></ref>
<ref id="B22">
<label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grooters</surname> <given-names>AM</given-names></name> <name><surname>Whittington</surname> <given-names>A</given-names></name> <name><surname>Lopez</surname> <given-names>MK</given-names></name> <name><surname>Boroughs</surname> <given-names>MN</given-names></name> <name><surname>Roy</surname> <given-names>AF</given-names></name></person-group>. <article-title>Evaluation of microbial culture techniques for the isolation of <italic>Pythium insidiosum</italic> from equine tissues.</article-title> <source><italic>J Vet Diagn Investig Off Publ Am Assoc Vet Lab Diagn Inc.</italic></source> (<year>2002</year>) <volume>14</volume>:<fpage>288</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1177/104063870201400403</pub-id> <pub-id pub-id-type="pmid">12152807</pub-id></mixed-citation></ref>
<ref id="B23">
<label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bala</surname> <given-names>K</given-names></name> <name><surname>Robideau</surname> <given-names>GP</given-names></name> <name><surname>D&#x00E9;saulniers</surname> <given-names>N</given-names></name> <name><surname>de Cock</surname> <given-names>AW</given-names></name> <name><surname>L&#x00E9;vesque</surname> <given-names>CA</given-names></name></person-group>. <article-title>Taxonomy, DNA barcoding and phylogeny of three new species of pythium from canada.</article-title> <source><italic>Persoonia.</italic></source> (<year>2010</year>) <volume>25</volume>:<fpage>22</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.3767/003158510X524754</pub-id> <pub-id pub-id-type="pmid">21339964</pub-id></mixed-citation></ref>
<ref id="B24">
<label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaiprasert</surname> <given-names>A</given-names></name> <name><surname>Samerpitak</surname> <given-names>K</given-names></name> <name><surname>Wanachiwanawin</surname> <given-names>W</given-names></name> <name><surname>Thasnakorn</surname> <given-names>P</given-names></name></person-group>. <article-title>Induction of zoospore formation in Thai isolates of <italic>Pythium insidiosum</italic>.</article-title> <source><italic>Mycoses.</italic></source> (<year>1990</year>) <volume>33</volume>:<fpage>317</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1111/myc.1990.33.6.317</pub-id> <pub-id pub-id-type="pmid">2259373</pub-id></mixed-citation></ref>
<ref id="B25">
<label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tondolo</surname> <given-names>JSM</given-names></name> <name><surname>Loreto</surname> <given-names>&#x00C9;S</given-names></name> <name><surname>Ledur</surname> <given-names>PC</given-names></name> <name><surname>Jesus</surname> <given-names>FPK</given-names></name> <name><surname>Silva</surname> <given-names>TM</given-names></name> <name><surname>Kommers</surname> <given-names>GD</given-names></name><etal/></person-group> <article-title>Chemically induced disseminated pythiosis in BALB/c mice: a new experimental model for <italic>Pythium insidiosum</italic> infection.</article-title> <source><italic>PloS One.</italic></source> (<year>2017</year>) <volume>12</volume>:<fpage>e0177868</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0177868</pub-id> <pub-id pub-id-type="pmid">28542438</pub-id></mixed-citation></ref>
<ref id="B26">
<label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santurio</surname> <given-names>JM</given-names></name> <name><surname>Leal</surname> <given-names>AT</given-names></name> <name><surname>Leal</surname> <given-names>AB</given-names></name> <name><surname>Festugatto</surname> <given-names>R</given-names></name> <name><surname>Lubeck</surname> <given-names>I</given-names></name> <name><surname>Sallis</surname> <given-names>ES</given-names></name><etal/></person-group> <article-title>Three types of immunotherapics against pythiosis insidiosi developed and evaluated.</article-title> <source><italic>Vaccine.</italic></source> (<year>2003</year>) <volume>21</volume>:<fpage>2535</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/s0264-410x(03)00035-5</pub-id> <pub-id pub-id-type="pmid">12744888</pub-id></mixed-citation></ref>
<ref id="B27">
<label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname> <given-names>RB</given-names></name> <name><surname>Pastor</surname> <given-names>A</given-names></name> <name><surname>Mendoza</surname> <given-names>L</given-names></name></person-group>. <article-title>Mapping of <italic>Pythium insidiosum</italic> hyphal antigens and ultrastructural features using TEM.</article-title> <source><italic>Mycol Res.</italic></source> (<year>2007</year>) <volume>111</volume>:<fpage>1352</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.mycres.2007.08.005</pub-id> <pub-id pub-id-type="pmid">18023165</pub-id></mixed-citation></ref>
<ref id="B28">
<label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x00E1;ndez Mir&#x00F3;</surname> <given-names>M</given-names></name> <name><surname>Colom Com&#x00ED;</surname> <given-names>C</given-names></name> <name><surname>Godoy Lorenzo</surname> <given-names>R</given-names></name></person-group>. <article-title>Autoinmune polyendocrinopathy.</article-title> <source><italic>Med Clin.</italic></source> (<year>2021</year>) <volume>157</volume>:<fpage>241</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.medcli.2021.02.004</pub-id> <pub-id pub-id-type="pmid">33958142</pub-id></mixed-citation></ref>
<ref id="B29">
<label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loreto</surname> <given-names>ES</given-names></name> <name><surname>Mario</surname> <given-names>DAN</given-names></name> <name><surname>Denardi</surname> <given-names>LB</given-names></name> <name><surname>Alves</surname> <given-names>SH</given-names></name> <name><surname>Santurio</surname> <given-names>JM</given-names></name></person-group>. <article-title>In vitro susceptibility of <italic>Pythium insidiosum</italic> to macrolides and tetracycline antibiotics.</article-title> <source><italic>Antimicrob Agents Chemother.</italic></source> (<year>2011</year>) <volume>55</volume>:<fpage>3588</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01586-10</pub-id> <pub-id pub-id-type="pmid">21537028</pub-id></mixed-citation></ref>
<ref id="B30">
<label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ianiski</surname> <given-names>LB</given-names></name> <name><surname>Stibbe</surname> <given-names>PC</given-names></name> <name><surname>Denardi</surname> <given-names>LB</given-names></name> <name><surname>Weiblen</surname> <given-names>C</given-names></name> <name><surname>Soares</surname> <given-names>MP</given-names></name> <name><surname>de Valente</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>In vitro anti-<italic>Pythium insidiosum</italic> activity of amorolfine hydrochloride and azithromycin, alone and in combination.</article-title> <source><italic>Med Mycol.</italic></source> (<year>2021</year>) <volume>59</volume>:<fpage>67</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1093/mmy/myaa032</pub-id> <pub-id pub-id-type="pmid">32400872</pub-id></mixed-citation></ref>
<ref id="B31">
<label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loreto</surname> <given-names>ES</given-names></name> <name><surname>Tondolo</surname> <given-names>JSM</given-names></name> <name><surname>de Jesus</surname> <given-names>FPK</given-names></name> <name><surname>Verdi</surname> <given-names>CM</given-names></name> <name><surname>Weiblen</surname> <given-names>C</given-names></name> <name><surname>de Azevedo</surname> <given-names>MI</given-names></name><etal/></person-group> <article-title>Efficacy of azithromycin and miltefosine in experimental systemic pythiosis in immunosuppressed mice.</article-title> <source><italic>Antimicrob Agents Chemother.</italic></source> (<year>2019</year>) <volume>63</volume>:<fpage>e1385</fpage>&#x2013;<lpage>1318</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01385-18</pub-id> <pub-id pub-id-type="pmid">30373795</pub-id></mixed-citation></ref>
<ref id="B32">
<label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schurko</surname> <given-names>A</given-names></name> <name><surname>Mendoza</surname> <given-names>L</given-names></name> <name><surname>de Cock</surname> <given-names>AWAM</given-names></name> <name><surname>Klassen</surname> <given-names>GR</given-names></name></person-group>. <article-title>Evidence for geographic clusters: Molecular genetic differences among strains of <italic>Pythium insidiosum</italic> from Asia. Australia and the Americas are explored.</article-title> <source><italic>Mycologia.</italic></source> (<year>2003</year>) <volume>95</volume>:<fpage>200</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1080/15572536.2004.11833105</pub-id></mixed-citation></ref>
<ref id="B33">
<label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tartor</surname> <given-names>YH</given-names></name> <name><surname>Hamad</surname> <given-names>MH</given-names></name> <name><surname>Abouzeid</surname> <given-names>NZ</given-names></name> <name><surname>El-Belkemy</surname> <given-names>FA</given-names></name></person-group>. <article-title>Equine pythiosis in egypt: Clinicopathological findings, detection, identification and genotyping of <italic>Pythium insidiosum</italic>.</article-title> <source><italic>Vet Dermatol.</italic></source> (<year>2020</year>) <volume>31</volume>:<fpage>298</fpage>&#x2013;<lpage>e73</lpage>. <pub-id pub-id-type="doi">10.1111/vde.12845</pub-id> <pub-id pub-id-type="pmid">32342602</pub-id></mixed-citation></ref>
<ref id="B34">
<label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mar Htun</surname> <given-names>Z</given-names></name> <name><surname>Laikul</surname> <given-names>A</given-names></name> <name><surname>Pathomsakulwong</surname> <given-names>W</given-names></name> <name><surname>Yurayart</surname> <given-names>C</given-names></name> <name><surname>Lohnoo</surname> <given-names>T</given-names></name> <name><surname>Yingyong</surname> <given-names>W</given-names></name><etal/></person-group> <article-title>Identification and biotyping of <italic>Pythium insidiosum</italic> isolated from urban and rural areas of Thailand by multiplex PCR, DNA barcode, and proteomic analyses.</article-title> <source><italic>J Fungi Basel Switz.</italic></source> (<year>2021</year>) <volume>7</volume>:<fpage>242</fpage>. <pub-id pub-id-type="doi">10.3390/jof7040242</pub-id> <pub-id pub-id-type="pmid">33804838</pub-id></mixed-citation></ref>
<ref id="B35">
<label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voget</surname> <given-names>M</given-names></name> <name><surname>Lorenz</surname> <given-names>D</given-names></name> <name><surname>Lieber-Tenorio</surname> <given-names>E</given-names></name> <name><surname>Hauck</surname> <given-names>R</given-names></name> <name><surname>Meyer</surname> <given-names>M</given-names></name> <name><surname>Cieslicki</surname> <given-names>M</given-names></name></person-group>. <article-title>Is transmission electron microscopy (TEM) a promising approach for qualitative and quantitative investigations of polymyxin B and miconazole interactions with cellular and subcellular structures of <italic>staphylococcus pseudintermedius</italic>, <italic>escherichia coli</italic>, <italic>pseudomonas aeruginosa</italic> and <italic>malassezia pachydermatis</italic>?</article-title> <source><italic>Vet Microbiol.</italic></source> (<year>2015</year>) <volume>181</volume>:<fpage>261</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetmic.2015.10.002</pub-id> <pub-id pub-id-type="pmid">26527257</pub-id></mixed-citation></ref>
<ref id="B36">
<label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>HT</given-names></name> <name><surname>O&#x2019;Donovan</surname> <given-names>LA</given-names></name> <name><surname>Venter</surname> <given-names>H</given-names></name> <name><surname>Russell</surname> <given-names>CC</given-names></name> <name><surname>McCluskey</surname> <given-names>A</given-names></name> <name><surname>Page</surname> <given-names>SW</given-names></name><etal/></person-group> <article-title>Comparison of two transmission electron microscopy methods to visualize drug-induced alterations of gram-negative bacterial morphology.</article-title> <source><italic>Antibiot Basel Switz.</italic></source> (<year>2021</year>) <volume>10</volume>:<fpage>307</fpage>. <pub-id pub-id-type="doi">10.3390/antibiotics10030307</pub-id> <pub-id pub-id-type="pmid">33802844</pub-id></mixed-citation></ref>
<ref id="B37">
<label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loreto</surname> <given-names>ES</given-names></name> <name><surname>Tondolo</surname> <given-names>JSM</given-names></name> <name><surname>Pilotto</surname> <given-names>MB</given-names></name> <name><surname>Alves</surname> <given-names>SH</given-names></name> <name><surname>Santurio</surname> <given-names>JM</given-names></name></person-group>. <article-title>New insights into the in vitro susceptibility of <italic>Pythium insidiosum</italic>.</article-title> <source><italic>Antimicrob Agents Chemother.</italic></source> (<year>2014</year>) <volume>58</volume>:<fpage>7534</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.02680-13</pub-id> <pub-id pub-id-type="pmid">25223997</pub-id></mixed-citation></ref>
<ref id="B38">
<label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torvorapanit</surname> <given-names>P</given-names></name> <name><surname>Chuleerarux</surname> <given-names>N</given-names></name> <name><surname>Plongla</surname> <given-names>R</given-names></name> <name><surname>Worasilchai</surname> <given-names>N</given-names></name> <name><surname>Manothummetha</surname> <given-names>K</given-names></name> <name><surname>Thongkam</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Clinical outcomes of radical surgery and antimicrobial agents in vascular pythiosis: a multicenter prospective study.</article-title> <source><italic>J Fungi Basel Switz.</italic></source> (<year>2021</year>) <volume>7</volume>:<fpage>114</fpage>. <pub-id pub-id-type="doi">10.3390/jof7020114</pub-id> <pub-id pub-id-type="pmid">33557064</pub-id></mixed-citation></ref>
<ref id="B39">
<label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stokes</surname> <given-names>JM</given-names></name> <name><surname>Lopatkin</surname> <given-names>AJ</given-names></name> <name><surname>Lobritz</surname> <given-names>MA</given-names></name> <name><surname>Collins</surname> <given-names>JJ</given-names></name></person-group>. <article-title>Bacterial metabolism and antibiotic efficacy.</article-title> <source><italic>Cell Metab.</italic></source> (<year>2019</year>) <volume>30</volume>:<fpage>251</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2019.06.009</pub-id> <pub-id pub-id-type="pmid">31279676</pub-id></mixed-citation></ref>
<ref id="B40">
<label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>H-Y</given-names></name> <name><surname>Kang</surname> <given-names>H-G</given-names></name> <name><surname>Kim</surname> <given-names>H-M</given-names></name> <name><surname>Jeong</surname> <given-names>H-J</given-names></name></person-group>. <article-title>Anti-tumor activity of trimethoprim-sulfamethoxazole against melanoma skin cancer through triggering allergic reaction and promoting immunity.</article-title> <source><italic>Int Immunopharmacol.</italic></source> (<year>2023</year>) <volume>123</volume>:<fpage>110742</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2023.110742</pub-id> <pub-id pub-id-type="pmid">37536185</pub-id></mixed-citation></ref>
<ref id="B41">
<label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torvorapanit</surname> <given-names>P</given-names></name> <name><surname>Worasilchai</surname> <given-names>N</given-names></name> <name><surname>Manothummetha</surname> <given-names>K</given-names></name> <name><surname>Srisurapanont</surname> <given-names>K</given-names></name> <name><surname>Thongkam</surname> <given-names>A</given-names></name> <name><surname>Langsiri</surname> <given-names>N</given-names></name><etal/></person-group> <article-title>Improved survival in vascular pythiosis with surgery and azithromycin, doxycycline, and itraconazole therapy: A phase II multicenter, open-label, single-arm trial.</article-title> <source><italic>Clin Infect Dis Off Publ Infect Dis Soc Am.</italic></source> (<year>2025</year>) <volume>80</volume>:<fpage>1281</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciaf062</pub-id> <pub-id pub-id-type="pmid">39932261</pub-id></mixed-citation></ref>
<ref id="B42">
<label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jesus</surname> <given-names>FPK</given-names></name> <name><surname>Ferreiro</surname> <given-names>L</given-names></name> <name><surname>Loreto</surname> <given-names>&#x00C9;S</given-names></name> <name><surname>Pilotto</surname> <given-names>MB</given-names></name> <name><surname>Ludwig</surname> <given-names>A</given-names></name> <name><surname>Bizzi</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against <italic>Pythium insidiosum</italic>.</article-title> <source><italic>Antimicrob Agents Chemother.</italic></source> (<year>2014</year>) <volume>58</volume>:<fpage>5621</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.02349-14</pub-id> <pub-id pub-id-type="pmid">25001300</pub-id></mixed-citation></ref>
<ref id="B43">
<label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worasilchai</surname> <given-names>N</given-names></name> <name><surname>Chindamporn</surname> <given-names>A</given-names></name> <name><surname>Plongla</surname> <given-names>R</given-names></name> <name><surname>Torvorapanit</surname> <given-names>P</given-names></name> <name><surname>Manothummetha</surname> <given-names>K</given-names></name> <name><surname>Chuleerarux</surname> <given-names>N</given-names></name><etal/></person-group> <article-title>In vitro susceptibility of Thai <italic>Pythium insidiosum</italic> isolates to antibacterial agents.</article-title> <source><italic>Antimicrob Agents Chemother.</italic></source> (<year>2020</year>) <volume>64</volume>:<fpage>e2099</fpage>&#x2013;<lpage>2019</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.02099-19</pub-id> <pub-id pub-id-type="pmid">32015039</pub-id></mixed-citation></ref>
<ref id="B44">
<label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagga</surname> <given-names>B</given-names></name> <name><surname>Kate</surname> <given-names>A</given-names></name> <name><surname>Mohamed</surname> <given-names>A</given-names></name> <name><surname>Sharma</surname> <given-names>S</given-names></name> <name><surname>Das</surname> <given-names>S</given-names></name> <name><surname>Mitra</surname> <given-names>S</given-names></name></person-group>. <article-title>Successful strategic management of <italic>Pythium insidiosum</italic> keratitis with antibiotics.</article-title> <source><italic>Ophthalmology.</italic></source> (<year>2021</year>) <volume>128</volume>:<fpage>169</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.ophtha.2020.05.046</pub-id> <pub-id pub-id-type="pmid">32505693</pub-id></mixed-citation></ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by"><p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/36794/overview">Shisan (Bob) Bao</ext-link>, The University of Sydney, Australia</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by"><p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/477975/overview">Tomasz Jagielski</ext-link>, University of Warsaw, Poland</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2755074/overview">Fatemeh Nikoomanesh</ext-link>, Birjand University of Medical Sciences, Iran</p></fn>
</fn-group>
<fn-group>
<fn id="footnote1"><label>1</label><p><ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov">https://pubmed.ncbi.nlm.nih.gov</ext-link></p></fn>
<fn id="footnote2"><label>2</label><p><ext-link ext-link-type="uri" xlink:href="https://scholar.google.com">https://scholar.google.com</ext-link></p></fn>
<fn id="footnote3"><label>3</label><p><ext-link ext-link-type="uri" xlink:href="https://blast.ncbi.nlm.nih.gov/Blast.cgi">https://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link></p></fn>
</fn-group>
<fn-group>
<fn fn-type="abbr" id="abbrev1">
<label>Abbreviations:</label><p>AZM, Azithromycin; CHL, Chloramphenicol; COI, Cytochrome oxidase; DOX, Doxycycline; ER, endoplasmic reticula; ERY, Erythromycin; FEI, Field Electron and Ion Company; GMS, Gomori Methenamine Silver; LSU, large subunit; LZD, Linezolid; MIC, minimum inhibitory concentration; PCR, polymerase chain reaction; <italic>P. insidiosum</italic>, <italic>Pythium insidiosum</italic>; SCAU, South China Agricultural University; SEM, Scanning Electron Microscopy; SMZ/TMP, compound sulfamethoxazole; TEM, Transmission Electron Microscopy; TET, Tetracyclin; TIG, Tigecycline.</p></fn>
</fn-group>
</back>
</article>